Crystal structure of an antidiabetic agent, (+/-)-5-[4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]-2,4-dioxothiazollidine, troglitazone dihydrate.
Kobayashi
K
K
Process Development Laboratories, Sankyo Co. Ltd, Hiratsuka, Kanagawa, Japan.
Fukuhara
H
H
Hata
T
T
D002839:Chromans / Q000737:chemistry*; D003460:Crystallization; D018360:Crystallography, X-Ray; D007004:Hypoglycemic Agents / Q000737:chemistry*; D013237:Stereoisomerism; D013844:Thiazoles / Q000737:chemistry*; D045162:Thiazolidinediones; D000077288:Troglitazone
C458441:5-(4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl)-2,4-dioxothiazollidine, troglitazone dihydrate; D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone